SWN
60
-6
ED
56
3
NKE
36
-3
XOM
48
-3
K
38
-3
WAT
55
2
AMZN
58
2
LNC
45
2
TMO
63
3
FTI
81
-3
L
55
5
NEE
59
5
PRGO
64
2
GME
62
-2
ES
38
2
URBN
52
-3
KEY
37
3
CB
47
3
EXR
46
6
EA
68
6
SWN
60
-6
ED
56
3
NKE
36
-3
XOM
48
-3
K
38
-3
WAT
55
2
AMZN
58
2
LNC
45
2
TMO
63
3
FTI
81
-3
L
55
5
NEE
59
5
PRGO
64
2
GME
62
-2
ES
38
2
URBN
52
-3
KEY
37
3
CB
47
3
EXR
46
6
EA
68
6
Financhill
Back

Pharming Group Quote, Financials, Valuation and Earnings

NOW is the time to get in on this trillion-dollar megatrend

Get it here.
Sell
44

PHAR
Pharming Group

Last Price:
9.80
Seasonality Move:
-0.25%

7 Day Trial

ALL ACCESS PASS

$ 7

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!

Pharming Group Price Quote

$9.80
-0.65 (-6.22%)
(Updated: May 2, 2024 at 12:45 PM ET)

Pharming Group Key Stats

Sell
44
Pharming Group (PHAR) is a Sell
Day range:
$9.80 - $10.45
52-week range:
$9.27 - $16.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.09
P/B ratio:
3.22%
Volume:
1.1K
Avg. volume:
2K
1-year change:
-5%
Market cap:
$703.7M
Revenue:
$245.3M
EPS:
$-0.16

How Much Does Pharming Group Make?

Is Pharming Group Growing As A Company?

  • What Is Pharming Group's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.49%
  • What Is Pharming Group's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Pharming Group Stock Price Performance

  • Did Pharming Group Stock Go Up Last Month?
    Pharming Group share price went down by -7.4% last month
  • Did PHAR's Share Price Rise Over The Last Year?
    PHAR share price fell by -5% over the past 1 year

What Is Pharming Group 52-Week High & Low?

Pharming Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Pharming Group?

  • How Much Debt Does Pharming Group Have?
    Total long term debt quarterly is $138.4M
  • How Much Cash Does Pharming Group Have?
    Cash and short term investments quarterly total is $213.4M
  • What Is Pharming Group’s Book Value Per Share?
    Book value per share is 3.26

Is Pharming Group Cash Flow Positive?

  • What Is PHAR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$17.3M
  • What Is Pharming Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1M
  • What Is Pharming Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$129.4M

Pharming Group Return On Invested Capital

  • Is Management Doing A Good Job?
    PHAR return on invested capital is -3.09%
  • What Is Pharming Group Return On Assets?
    ROA measures how assets are converting to revenues and is -2.42%
  • What Is PHAR Return On Equity?
    ROE is a measure of profitability and is -5.11%

Pharming Group Earnings Date & Stock Price

Pharming Group Competitors

Pharming Group Dividend Yield

Data Unavailable

Pharming Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -188.89%
Revenue: 48.69% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 38.50
Upside from Last Price: 268.42%

Major Shareholders

  • How many PHAR shares are owned by institutional investors?
    38.5M PHAR shares are owned by institutional investors
  • How many PHAR shares are owned by insiders?
    0 PHAR shares are owned by insiders